主要从事急、慢性白血病的临床诊疗工作以及白血病发病机制基础研究。

1、Reinduction chemotherapy regimen involved decitabine and cladribine improves the prognosis of patients with relapsed or refractory acute myeloid leukemia: A preliminary study, international journal of cancer, 2021, 149(4): 901-908.

2、Heterogeneity analysis of the CEBPAdm AML based on bZIP region mutations, Blood Science, 2023, Publish Ahead of Print: 101-105

3、Serum albumin is associated with the inherent property of acute myeloid leukemia and correlates with patient outcomes. Blood Sci. 2024 May 10;6(2):e00189.

4、Dynamin2 mutations in newly diagnosed acute myeloid leukemia: clinical characteristics, and prognostic significance. Exp Hematol Oncol. 2025 Mar 21;14(1):42.

天津市康复医学会血液病康复专委会秘书